The first method relied on the isolation of EVs from the plasma of CML patients via ExoQuickTM Exosome Precipitation Solution and the identification of BCR::ABL1 transcripts based on nested PCR. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.